Genting places $112m bet on TauRx to untangle Alzheimer's
This article was originally published in Scrip
As the largest operator of casinos and resorts in Malaysia, Genting Berhad is used to the odds favoring the house. It is now hoping that its latest bet in healthcare will also pay off handsomely.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.